valspodar: Clinical Trials

4 trials of valspodar, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4

Follow valspodar: new trials by email Literature Review of valspodar trials Research Report on valspodar

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
cytarabine, daunorubicin hydrochloride, etoposide - Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia
Phase 3CompletedNational Cancer Institute (NCI)7202000-11-012013-06-04
Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
cytarabine, daunorubicin hydrochloride, etoposide - Leukemia, Myelodysplastic Syndromes
Phase 3CompletedLeukemia Research Fund20001998-12-012013-12-18
Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia
cytarabine, daunorubicin hydrochloride, etoposide - Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0)
Phase 3CompletedNational Cancer Institute (NCI)6401998-01-012013-06-04
Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma
dexamethasone, doxorubicin hydrochloride, valspodar - Multiple Myeloma and Plasma Cell Neoplasm
Phase 3CompletedEastern Cooperative Oncology Group1997-06-302023-06-15

Conditions studied

Congenital Abnormalities (3)  ·  Leukemia, Erythroblastic, Acute (3)  ·  Leukemia, Megakaryoblastic, Acute (3)  ·  Leukemia, Monocytic, Acute (3)  ·  Leukemia, Myeloid, Acute (3)  ·  Leukemia, Myelomonocytic, Acute (3)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  Leukemia (1)  ·  Leukemia, Basophilic, Acute (1)  ·  Leukemia, Eosinophilic, Acute (1)  ·  Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (1)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Multiple Myeloma (1)  ·  Myelodysplastic Syndromes (1)  ·  Myelodysplastic-Myeloproliferative Diseases (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  Eastern Cooperative Oncology Group (1)  ·  Leukemia Research Fund (1)

Countries

United States (3)  ·  Canada (1)  ·  United Kingdom (1)

Top investigators

Alan K. Burnett, MD, FRCP (1)  ·  Chaim Shustik, MD (1)  ·  Jonathan Kolitz (1)  ·  Karl H. Hanson, MD (1)  ·  Maria Baer (1)  ·  Pieter Sonneveld, MD, PhD (1)  ·  Richard A. Larson, MD (1)  ·  William R. Friedenberg, MD (1)

Results publications

PMID 31375516, PMID 36184192, PMID 16419071, PMID 17315155, PMID 19291085, PMID 20522709, PMID 34162404

NIH funding

U10CA031946 (2)